Treating rheumatoid arthritis with tumour necrosis factor alpha blockade.
作者信息
Emery Paul, Buch Maya
出版信息
BMJ. 2002 Feb 9;324(7333):312-3. doi: 10.1136/bmj.324.7333.312.
Abstract
摘要
相似文献
1
Treating rheumatoid arthritis with tumour necrosis factor alpha blockade.使用肿瘤坏死因子α阻滞剂治疗类风湿性关节炎。
BMJ. 2002 Feb 9;324(7333):312-3. doi: 10.1136/bmj.324.7333.312.
2
Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment.使用抗肿瘤坏死因子α治疗药物英夫利昔单抗治疗类风湿关节炎的临床试验综述。
Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I61-4. doi: 10.1136/ard.58.2008.i61.
3
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.抗肿瘤坏死因子特异性抗体（英夫利昔单抗）治疗为类风湿关节炎的病理生理学提供了深入见解。
Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I56-60. doi: 10.1136/ard.58.2008.i56.
4
Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.类风湿关节炎中的抗肿瘤坏死因子α治疗——现状与未来方向
Curr Dir Autoimmun. 2000;2:83-102. doi: 10.1159/000060499.
5
Tumour necrosis factor blockade in rheumatoid arthritis.类风湿关节炎中的肿瘤坏死因子阻断疗法
Clin Med (Lond). 2001 Mar-Apr;1(2):107-9. doi: 10.7861/clinmedicine.1-2-107.
6
[Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].[抗TNF-α单克隆抗体在类风湿关节炎治疗中的应用]
Rev Med Interne. 2000 Oct;21(10):854-62. doi: 10.1016/s0248-8663(00)00236-8.
7
Effects of tumor necrosis factor-alpha inhibitors on lung lesions with rheumatoid arthritis.
Chest. 2003 Jul;124(1):413-4; author reply 414.
8
Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis.肿瘤坏死因子-α拮抗剂在类风湿关节炎治疗中的应用
Rheum Dis Clin North Am. 2001 May;27(2):427-43. doi: 10.1016/s0889-857x(05)70211-8.
9
[Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].英夫利昔单抗或依那西普抑制肿瘤坏死因子治疗类风湿关节炎
Ned Tijdschr Geneeskd. 2001 Nov 24;145(47):2294-5.
10
Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials.阿达木单抗（一种全人源抗肿瘤坏死因子α单克隆抗体）治疗活动性类风湿关节炎：五项试验的初步结果。
Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii70-3. doi: 10.1136/ard.61.suppl_2.ii70.
引用本文的文献
1
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis.阻断趋化因子受体可减轻胶原诱导性关节炎中的滑膜炎和关节破坏。
J Mol Med (Berl). 2023 May;101(5):569-580. doi: 10.1007/s00109-023-02307-6. Epub 2023 Mar 29.
2
The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines.澳大利亚高成本药品的资金投入与使用：以抗风湿生物药为例。
Aust New Zealand Health Policy. 2007 Mar 1;4:2. doi: 10.1186/1743-8462-4-2.
3
Removing barriers for disabled people would be giant leap.消除残疾人面临的障碍将是一个巨大的飞跃。
BMJ. 2002 May 4;324(7345):1101. doi: 10.1136/bmj.324.7345.1101.
本文引用的文献
1
WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis.
Rheumatology (Oxford). 2001 Jun;40(6):699-702. doi: 10.1093/rheumatology/40.6.699.
2
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.英夫利昔单抗与甲氨蝶呤治疗类风湿关节炎。类风湿关节炎联合治疗抗肿瘤坏死因子试验研究组。
N Engl J Med. 2000 Nov 30;343(22):1594-602. doi: 10.1056/NEJM200011303432202.
3
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.早期类风湿关节炎患者中依那西普与甲氨蝶呤的比较。
N Engl J Med. 2000 Nov 30;343(22):1586-93. doi: 10.1056/NEJM200011303432201.
4
Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis.关于类风湿关节炎中肿瘤坏死因子阻断疗法起始与持续应用的共识声明。
Ann Rheum Dis. 2000 Jul;59(7):504-5. doi: 10.1136/ard.59.7.504.
5
Targeted therapies in rheumatoid arthritis: the need for action.
Rheumatology (Oxford). 1999 Oct;38(10):911-2. doi: 10.1093/rheumatology/38.10.911.
6
7
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.类风湿关节炎的依那西普治疗。一项随机对照试验。
Ann Intern Med. 1999 Mar 16;130(6):478-86. doi: 10.7326/0003-4819-130-6-199903160-00004.
8
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.多次静脉输注抗肿瘤坏死因子α单克隆抗体联合小剂量每周一次甲氨蝶呤治疗类风湿关节炎的疗效
Arthritis Rheum. 1998 Sep;41(9):1552-63. doi: 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W.
9
Role of cytokines in rheumatoid arthritis.细胞因子在类风湿关节炎中的作用。
Annu Rev Immunol. 1996;14:397-440. doi: 10.1146/annurev.immunol.14.1.397.
10
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.嵌合型肿瘤坏死因子α单克隆抗体（cA2）与安慰剂治疗类风湿关节炎的随机双盲对照研究
Lancet. 1994 Oct 22;344(8930):1105-10. doi: 10.1016/s0140-6736(94)90628-9.
Zotero 插件